Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan
-
Published:2019
Issue:5
Volume:8
Page:403-411
-
ISSN:2235-1795
-
Container-title:Liver Cancer
-
language:en
-
Short-container-title:Liver Cancer
Author:
Hiraoka AtsushiORCID, Michitaka Kojiro, Kumada Takashi, Izumi Namiki, Kadoya Masumi, Kokudo Norihiro, Kubo Shoji, Matsuyama Yutaka, Nakashima Osamu, Sakamoto Michiie, Takayama Tadatoshi, Kokudo Takashi, Kashiwabara Kosuke, Eguchi Susumu, Yamashita Tatsuya, Kudo Masatoshi,
Subject
Oncology,Hepatology
Reference30 articles.
1. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38. 2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012 Mar;379(9822):1245–55. 3. Dufour JF, Bargellini I, De Maria N, De Simone P, Goulis I, Marinho RT. Intermediate hepatocellular carcinoma: current treatments and future perspectives. Ann Oncol. 2013 Apr;24 Suppl 2:ii24–9. 4. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, et al.; Liver Cancer Study Group of Japan. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer. 2014 Oct;3(3-4):458–68. 5. Hiraoka A, Kumada T, Kudo M, Hirooka M, Koizumi Y, Hiasa Y, et al.; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: multicenter Analysis. Dig Dis. 2017;35(6):602–10.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|